Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Horticulture Research
|
January 18, 2022
The reference genome of camellia chekiangoleosa provides insights into camellia evolution and tea oil biosynthesis
Teng-Fei Shen, Bin Huang, Meng Xu, et al.
Journal of Clinical Pharmacology
|
March 5, 2022
Effect of Mild and Moderate Hepatic Impairment (Defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
Hamim Zahir, Jonathan Greenberg, Ching Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer
Shirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.
Gut
|
March 7, 2013
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer, William J Sandborn, Yuriy Stepanov, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 24, 2023
Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens
Wenqin Feng, Ryotaku Inoue, Takeshi Kuwata, et al.
Arthritis and Rheumatism
|
December 8, 2011
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Michael Yellin, Igor Paliienko, Andra Balanescu, et al.
Journal of Crohn'S & Colitis
|
January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer
José Baselga, Milvia Zambetti, Antoni Llombart-Cussac, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Horticulture Research
|
January 18, 2022
The reference genome of camellia chekiangoleosa provides insights into camellia evolution and tea oil biosynthesis
Teng-Fei Shen, Bin Huang, Meng Xu, et al.
Journal of Clinical Pharmacology
|
March 5, 2022
Effect of Mild and Moderate Hepatic Impairment (Defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
Hamim Zahir, Jonathan Greenberg, Ching Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer
Shirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.
Gut
|
March 7, 2013
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Lloyd Mayer, William J Sandborn, Yuriy Stepanov, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
April 24, 2023
Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens
Wenqin Feng, Ryotaku Inoue, Takeshi Kuwata, et al.
Arthritis and Rheumatism
|
December 8, 2011
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
Michael Yellin, Igor Paliienko, Andra Balanescu, et al.
Journal of Crohn'S & Colitis
|
January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
William J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer
José Baselga, Milvia Zambetti, Antoni Llombart-Cussac, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
Page
of 5